Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111905263 | 11190526 | 3 | F | 20150414 | 20160721 | 20150615 | 20160727 | EXP | FR-GLAXOSMITHKLINE-FR2015GSK068102 | GLAXOSMITHKLINE | 48.22 | YR | F | Y | 55.00000 | KG | 20160727 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111905263 | 11190526 | 1 | PS | Pazopanib | PAZOPANIB | 1 | Oral | 800 MG, QD | U | 22465 | 800 | MG | QD | ||||||
| 111905263 | 11190526 | 2 | SS | Pazopanib | PAZOPANIB | 1 | Oral | UNK | U | 22465 | |||||||||
| 111905263 | 11190526 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1510 MG, UNK | U | 0 | 1510 | MG | |||||||
| 111905263 | 11190526 | 4 | C | SCHERISOLON | 2 | Unknown | U | 0 | |||||||||||
| 111905263 | 11190526 | 5 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 111905263 | 11190526 | 6 | C | ENKALI | 2 | Unknown | U | 0 | |||||||||||
| 111905263 | 11190526 | 7 | C | OXIFAST | OXYCODONE | 1 | Unknown | U | 0 | ||||||||||
| 111905263 | 11190526 | 8 | C | CALSIL (JAPAN) | 2 | Unknown | U | 0 | |||||||||||
| 111905263 | 11190526 | 9 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 111905263 | 11190526 | 10 | C | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 111905263 | 11190526 | 11 | C | FUNGIZONE | AMPHOTERICIN B | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111905263 | 11190526 | 1 | Soft tissue sarcoma |
| 111905263 | 11190526 | 3 | Soft tissue sarcoma |
| 111905263 | 11190526 | 4 | Product used for unknown indication |
| 111905263 | 11190526 | 5 | Product used for unknown indication |
| 111905263 | 11190526 | 6 | Product used for unknown indication |
| 111905263 | 11190526 | 7 | Product used for unknown indication |
| 111905263 | 11190526 | 8 | Product used for unknown indication |
| 111905263 | 11190526 | 9 | Product used for unknown indication |
| 111905263 | 11190526 | 10 | Product used for unknown indication |
| 111905263 | 11190526 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111905263 | 11190526 | HO |
| 111905263 | 11190526 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111905263 | 11190526 | Anxiety | |
| 111905263 | 11190526 | Asthenia | |
| 111905263 | 11190526 | General physical health deterioration | |
| 111905263 | 11190526 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111905263 | 11190526 | 1 | 20150330 | 0 | ||
| 111905263 | 11190526 | 2 | 20150422 | 0 | ||
| 111905263 | 11190526 | 3 | 20150330 | 0 |